Increased nerve-growth-factor beta-chain cross-reacting material in familial dysautonomia.
To determine whether dysautonomia arises from alteration in nerve-growth factor (NGF), we measured serum levels of NGF subunits in normal and dysautonomic subjects using a biologic assay based on neurite outgrowth from chick ganglions, a binding assay based on displacement of radiolabeled betaNGF from rabbit-ganglion microsomes, and radioimmunoassays of chi, gamma and betaNGF subunits via antiserum to mouse NGF polypeptides. A threefold increase (P less than 0.001) in serum antigen levels of the biologically active subunit (betaNGF) was found for dysautonomic as compared with normal subjects. By all other assays, the groups were alike. The marked discrepancy in betaNGF levels between antigenic and functional (biologic and binding) measurements suggests a qualitative abnormaltiy of betaNGF in dysautonomia. Alternatively, elevation of betaNGF antigen can be regarded as secondary to disease. This alternative seems less likely since we must then suppose that the normalcy of functional assays in spurious.
D000293:Adolescent; D000818:Animals; D000941:Antigens; D001667:Binding, Competitive; D001681:Biological Assay; D002648:Child; D003429:Cross Reactions; D004402:Dysautonomia, Familial / Q000097:blood* / Q000276:immunology; D005260:Female; D006801:Humans; D008297:Male; D051379:Mice / Q000276:immunology; D009414:Nerve Growth Factors / Q000097:blood* / Q000276:immunology; D010446:Peptide Fragments; D010455:Peptides / Q000097:blood / Q000276:immunology; D011817:Rabbits / Q000276:immunology; D011863:Radioimmunoassay
D000941:Antigens; D009414:Nerve Growth Factors; D010446:Peptide Fragments; D010455:Peptides